Autopsy report · NCT03715023

Anti-viral Effect of PC786 on RSV Infection on HSCT Recipients

“Practical issues that could not be resolved resulting in recruitment difficulties at sites.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 6 months before it stopped.
• 5 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Pulmocide Ltd

Sponsor type

Industry

Conditions

Respiratory Syncytial Virus Infections

Interventions

PC786; Placebo; SOC

Participants

5

Sites

7

Countries

United Kingdom

Trials that died the same way

• Efficacy of Angiographic Embolization vs Non-embolization of Moderate/Poor Vascularized Vertebral Metastases on Intraoperative Bleeding During Surgery Decompression and Vertebral Stabilization.
  “Difficulties in recruitment.” (78% match in meaning)
• Effect of Oral Appliance Therapy on Atrial Fibrillation
  “Recruitment difficulties.” (78% match in meaning)
• Immune Responses in Patients Treated With Raltegravir
  “Unexpected and severe difficulties in recruitment.” (75% match in meaning)
• Robotic Decompression of the Pudendal Nerve in Pudendal Neuralgia
  “recruitments difficulties” (75% match in meaning)
• DLBS1033 for the Treatment of Acute Ischemic Stroke
  “Major technical hindrance in recruitment.” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.